Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism D1 receptor antagonists(Dopamine D1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H29ClN2O |
InChIKeyJMLZYVMMUDKHMM-UHFFFAOYSA-N |
CAS Registry171285-42-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cocaine-Related Disorders | Phase 2 | US | - | |
Psychotic Disorders | Phase 2 | US | - |